About NC-CHF

The Citizens for Healthcare Freedom is a North Carolina grassroots organization dedicated to protect the right of our citizens to choose natural health options for themselves and their families.
The North Carolina Citizens for Healthcare Freedom is affliated with the American Association of Health Freedom.

Cancer and Vitamin C

Written by Dr. Bill Bailey on Nov 8th, 2007 | Filed under: General News & Information

Many years ago, Dr. Linus Pauling pioneered what he called “Orthomolecular” treatment via large doses (mega-doses) of Vitamin C for cancer with promising results… now, some research shows that this approach may have merit, and why.

A New Understanding of The Effect Of Vitamin C on Cancer Cells

“More than thirty years ago Linus Pauling and coworkers pioneered the therapeutic use of high doses of vitamin C (ascorbate) on terminal cancer patients, with promising results. Attempts by mainstream medicine to confirm Pauling’s results failed, largely because patients were given vitamin C orally, whereas Pauling’s group had gone the intravenous route. Intravenous administration achieves ascorbate concentrations that are orders of magnitude higher. Neglected by mainstream medicine, intravenous vitamin C cancer treatment continued as an alternative medical practice, although the establishment of the U.S. National Cancer Institute Best Case Series prompted a recent report of three well-documented case studies of successful vitamin C cancer therapy(1). There was another reason for the mainstream’s skepticism - the proposed mechanism of action of ascorbate appeared questionable. It was assumed that the antioxidant simply protected DNA from free radical damage, but this should protect the genetic material of healthy and cancerous tissues alike. The idea that ensuring DNA integrity should selectively favor healthy tissue over tumors seemed implausible. Indeed, this interpretation turned out to be wrong. A group at Johns Hopkins Medical School reported recently that antioxidants inhibited three tumorigenic models in vivo, but that ‘[inhibition of a human B lymphoma model was] unassociated with genomic instability but was linked to diminished hypoxia-inducible factor (HIF) levels…’(2). What the researchers found was that the differential effect of ascorbate on healthy tissue and cancer cells had nothing to do with the protection of DNA. Instead, ascorbate influenced the HIF-promoted transcription of selected genes. It was the suppression of the transcription of these genes by ascorbate that affected tumors and healthy tissues differently.

What is hypoxia-inducible factor (HIF)?

Hypoxia-inducible factor regulates the transcription of genes involved in angiogenesis, glucose uptake and metabolism, as well as other cellular functions. HIF is a protein that occurs in all mammalian cell types and that is activated when oxygen levels fall(3). Normal oxygen levels deactivate HIF by hydroxylating key proline and asparagine residues. These hydroxylation reactions are catalyzed by enzymes containing divalent iron at the active site, and require molecular oxygen. Ascorbate is needed to keep iron in the ferrous (divalent) state for these HIF-deactivating enzymes to function properly. HIF deactivation in turn prevents or slows gene transcription of proteins promoting angiogenesis and glucose metabolism(3) A growing tumor, unlike healthy tissue, needs new blood vessels (angiogenesis) to ensure a continuous supply of nutrients. And it had been known that HIF is often activated in solid tumors(3). Suppression of angiogenesis by deactivating hypoxia-inducible factor therefore selectively disadvantages tumor cells.”

Leave a Reply

GoodSearch: You Search...We Give!

NC-CHF Tote Bag
Support NC-CHF!  Buy our Logo
Products and a portion of your
purchase will support Health
Freedom!  (Click on the bag!)

Join Our Newsletter Email List

Fields marked like this are required.